|
Gilpin, Adele M Kaplan; Holbrook, Janet T; Jabs, Douglas A et al. (2003) Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Control Clin Trials 24:92-8
|
|
Holbrook, Janet T; Jabs, Douglas A; Weinberg, David V et al. (2003) Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 121:99-107
|
|
Jabs, Douglas A; Gilpin, Adele M Kaplan; Min, Yuan-I et al. (2002) HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS 16:877-87
|
|
Martin, B K; Kaplan Gilpin, A M; Jabs, D A et al. (2001) Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 54:376-86
|
|
Holbrook, J T; Meinert, C L; Jabs, D A et al. (2001) Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis. Control Clin Trials 22:62-8
|
|
Holbrook, J T; Meinert, C L; Van Natta, M L et al. (2001) Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. Arch Ophthalmol 119:554-63
|
|
Raffalli, J; Sepkowitz, K A; Armstrong, D (1996) Community-based outbreaks of tuberculosis. Arch Intern Med 156:1053-60
|
|
Gottlieb, S L; Myskowski, P L (1994) Molluscum contagiosum. Int J Dermatol 33:453-61
|
|
Sepkowitz, K A (1994) Tuberculosis and the health care worker: a historical perspective. Ann Intern Med 120:71-9
|
|
Sepkowitz, K; Schluger, N; Godwin, T et al. (1993) DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states. J Infect Dis 168:421-6
|
Showing the most recent 10 out of 25 publications
